新冠疫情期间慢性肝脏疾病医疗照护的调整：必要性还是新颖性？

Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?

机构信息

Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University,Egypt.

Department of Hepatology, Gastroenterology and infectious disease Faculty of Medicine, Kafrelsheikh University,Egypt.

出版信息

Infect Disord Drug Targets. 2021;21(8):e160921189886. doi: 10.2174/1871526520666210104152256.

DOI:10.2174/1871526520666210104152256

PMID:33397247

Abstract

In late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic of the 21st century. It seems that this infection will persist which is long enough to obligate modifications in both lifestyle and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shed light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.

摘要

2019 年末，新型冠状病毒（SARS-COV 2）在中国武汉出现，并传播到所有国家，引发了 21 世纪的首次大流行。这种感染似乎会持续存在，足以促使生活方式和医疗保健系统发生改变。由于慢性肝脏疾病（CLD）在世界各地普遍存在，因此预计将管理患有 CLD 和 COVID-19 的患者。本综述的目的是阐明 COVID-19 大流行对 CLD 患者管理的影响，以及在 COVID-19 大流行期间如何为 CLD 患者提供医疗护理。